Small Cell Lung Cancer

Showing NaN - NaN of 28

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer Trial in Worldwide (Tarlatamab, Placebo)

Not yet recruiting
  • Limited Stage Small Cell Lung Cancer
  • Small Cell Lung Cancer
  • Minneapolis, Minnesota
  • +124 more
Oct 31, 2023

Small Cell Lung Cancer Trial in Worldwide (biological, drug, radiation)

Recruiting
  • Small Cell Lung Cancer
  • Pembrolizumab 200 mg
  • +8 more
  • Chandler, Arizona
  • +170 more
Feb 2, 2023

Small Cell Lung Cancer Trial in Worldwide (Pembrolizumab, MK-4830, MK-5890)

Recruiting
  • Small Cell Lung Cancer
  • Pembrolizumab
  • +6 more
  • Gilbert, Arizona
  • +48 more
Jan 19, 2023

Small Cell Lung Cancer Trial in Worldwide (Tiragolumab, Atezolizumab, Carboplatin)

Active, not recruiting
  • Small Cell Lung Cancer
  • Lone Tree, Colorado
  • +123 more
Dec 21, 2022

Small Cell Lung Cancer, NSCLC, Squamous, NSCLC, Non-squamous Trial in Worldwide (ladiratuzumab vedotin)

Recruiting
  • Small Cell Lung Cancer
  • +8 more
  • Chandler, Arizona
  • +65 more
Dec 19, 2022

Small Cell Lung Cancer Trial in Worldwide (ADI-PEG 20 (Arginine deiminase pegylated))

Terminated
  • Small Cell Lung Cancer
  • ADI-PEG 20 (Arginine deiminase pegylated)
  • New York, New York
  • +7 more
Oct 3, 2022

Small Cell Lung Cancer Trial in Worldwide (ABBV-011, Budigalimab)

Recruiting
  • Small Cell Lung Cancer
  • Birmingham, Alabama
  • +32 more
Oct 5, 2022

Small Cell Lung Cancer Trial in Worldwide (BMS-986012 (anti-fucosyl-GM1), Nivolumab)

Active, not recruiting
  • Small Cell Lung Cancer
  • BMS-986012 (anti-fucosyl-GM1)
  • Nivolumab
  • New York, New York
  • +15 more
Sep 28, 2022

Merkel Cell Carcinoma, Small Cell Lung Cancer Trial in United States (XmAb18087, XmAb18087 ± Pembrolizumab)

Completed
  • Merkel Cell Carcinoma
  • Small Cell Lung Cancer
  • XmAb18087
  • XmAb18087 ± Pembrolizumab
  • Duarte, California
  • +6 more
Aug 8, 2022

Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma Trial in United States (PLX2853)

Completed
  • Small Cell Lung Cancer
  • +7 more
  • Scottsdale, Arizona
  • +4 more
Jul 20, 2022

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • +12 more
  • San Francisco, California
  • +44 more
Jul 12, 2022

Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer Trial in United States (PF-07104091 monotherapy dose escalation,

Recruiting
  • Small Cell Lung Cancer
  • +4 more
  • PF-07104091 monotherapy dose escalation
  • +8 more
  • Clive, Iowa
  • +22 more
Apr 26, 2022

Metastatic Solid Tumor, Colorectal Cancer, Neuroendocrine Tumors Trial in United States (Surufatinib and Tislelizumab _ Part 1,

Recruiting
  • Metastatic Solid Tumor
  • +6 more
  • Surufatinib and Tislelizumab _ Part 1
  • Surufatinib and Tislelizumab _ Part 2
  • Tucson, Arizona
  • +17 more
Apr 1, 2022

Melanoma (Excluding Uveal Melanoma), Cervical Carcinoma, Pancreatic Carcinoma Trial in United States (XmAb®23104, Yervoy®

Recruiting
  • Melanoma (Excluding Uveal Melanoma)
  • +15 more
  • XmAb®23104
  • Yervoy® (ipilimumab)
  • San Diego, California
  • +15 more
Sep 20, 2021

Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))

Completed
  • Gastric Adenocarcinoma
  • +15 more
  • Sacituzumab Govitecan-hziy (SG)
  • Aurora, Colorado
  • +11 more
Aug 10, 2021

Small Cell Lung Cancer Trial in Worldwide (LY3295668 Erbumine)

Completed
  • Small Cell Lung Cancer
  • LY3295668 Erbumine
  • Fayetteville, Arkansas
  • +39 more
Jul 30, 2021

Small Cell Lung Cancer Trial in Worldwide (Placebo for dexamethasone, Placebo for rovalpituzumab tesirine, Rovalpituzumab

Terminated
  • Small Cell Lung Cancer
  • Placebo for dexamethasone
  • +3 more
  • Huntsville, Alabama
  • +307 more
Jul 28, 2021

Liver Cancer, Anxiety Disorder, Depression Trial in United States (Early palliative care)

Completed
  • Liver Cancer
  • +9 more
  • Early palliative care
  • La Jolla, California
  • +22 more
Jul 22, 2021

Small Cell Lung Cancer Trial in Worldwide (Ipilimumab, Nivolumab, Rovalpituzumab tesirine)

Terminated
  • Small Cell Lung Cancer
  • La Jolla, California
  • +34 more
Jul 1, 2020

Breast Cancer, Ovarian Cancer, Gynecological Cancer Trial in New York, Madrid, Bellinzona (PM01183 + paclitaxel +/- bevacizumab)

Completed
  • Breast Cancer
  • +6 more
  • PM01183 + paclitaxel +/- bevacizumab
  • New York, New York
  • +2 more
Mar 24, 2020

Small Cell Lung Cancer Trial in United States (SC-002)

Terminated
  • Small Cell Lung Cancer
  • Ann Arbor, Michigan
  • +3 more
Oct 3, 2018

Carcinoma, Small Cell, Small Cell Lung Cancer Trial in Canada, United States (SNS-595)

Completed
  • Carcinoma, Small Cell
  • Small Cell Lung Cancer
  • Sacramento, California
  • +16 more
Oct 19, 2017

Lung Cancer, Small Cell Lung Cancer, NSCLC Trial in Worldwide (Ipilimumab, Placebo, Paclitaxel)

Completed
  • Lung Cancer
  • +2 more
  • Birmingham, Alabama
  • +71 more
Jun 18, 2018

Small Cell Lung Cancer, NSCLC Trial in United States (XMT-1001)

Completed
  • Small Cell Lung Cancer
  • Non-small Cell Lung Cancer
  • Scottsdale, Arizona
  • +11 more
Jan 29, 2018